SYNTARA LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 AUD | -11.76% |
|
-11.76% | -25.00% |
| Apr. 10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
| Feb. 29 | Syntara Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.0180 | 0.0220 | 0.0290 |
| Spread/Res. | -16.67% | -31.82% | -48.28% |
| Spread/Supp. | +15.38% | +36.36% | +66.67% |
| Support | 0.0130 | 0.0110 | 0.009000 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SNT Stock
- Charts Syntara Limited
